testing 2020

FDA report evaluates CBD product labeling accuracy

Reading now: 360
www.medicalnewstoday.com

legalizing products derived from cannabis, most often allowing their consumption for medical purposes, and in some cases, recreational use.However, with increased legalization, specialists have raised concerns regarding potential risks, particularly those linked to the use of unregulated cannabis-derived products.Such products can contain one or two of the main active compounds present in cannabis: cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC).While both of these substances interact with the same receptors in the human body once ingested, they can produce different effects.

While CBD is unlikely to lead to a “high,” THC is a psychoactive substance that can elicit this response.So far, products containing CBD have not been.

Read more on medicalnewstoday.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA